CLINICAL DEVELOPMENT AND THE DEVELOPMENT PROCESS INVOLVED IN BRINGING NEW MEDICINES TO THE MARKET
Saurabh D. Bhandare*
Abstract
There are multiple concerns involved in drug development process.
The process involved has stage of development of drug molecule. This
developed drug molecules are put forth to studies for proving its
Quality, Efficacy and are validated for its procedural development
upon a development of a drug molecule in a research laboratory.
(Pharmaceutical Research Laboratory) it is evaluated for its therapeutic
activity and are clinically tested and evaluated for its assigned activity.
There are various drug regulatory agencies involved in this process and
are based on continuous monitoring process that is called as ongoing
monitoring. This monitoring are carried out by clinical experts such as:
pharmacists and physicians. This clinical experts are involved in to
assists the clinical safety data on a clinical safety evaluation of a drug molecule or an entity
as an API. These studies are carried based on the guidelines that are accepted internationally.
(ICH). One goal of such on-site monitoring is to ensure that you have the right information at
right time and right place. Such on-site monitoring ensures that Healthcare is an excellent and
most trusted industry that could provide and nurture mankind for its continuous advanced
human health care to deliver valued and real outcome. Sustainability is a critical
consideration and thus involves (OHDSI) in its safety monitoring process.
Keywords: Clinical development, Drug Molecules, Formulation Safety, Regulatory Agencies.
[Full Text Article]